From Europe. For the global patent community.
Trending Topics:
JUVE Patent Healthcare

Healthcare

Cases
Pharmaceuticals

Akebia defends anaemia drug patents at EPO amid huge Fibrogen battle

Akebia Therapeutics has successfully defended two patents integral to a drug used to treat anaemia resulting from chronic kidney disease. The result i ...

1 March 2024 by Amy Sandys
People & Business
UK

Allen & Overy strengthens life sciences expertise with Bristows hire

Just before it becomes A&O Shearman, the London office of international firm Allen & Overy has hired Gemma Barrett as a partner in its IP team ...

27 February 2024 by Amy Sandys
Cases
Medical devices

French court rules that clinical trials can constitute patent infringement

Insulet has once again been successful against Medtrum at the Judicial Court of Paris, which found an Insulet patent for an insulin delivery system fo ...

27 February 2024 by Amy Sandys
Cases
Unified Patent Court

Court of Appeal judges pave way back to European market for NanoString

The Court of Appeal today overturned the Munich local division's preliminary injunction against NanoString in Europe, allowing the company to return t ...

26 February 2024 by Mathieu Klos
Cases
Damages

Mundipharma and Allen & Overy prevail after Glenmark damages claim

In a dispute over high-selling painkiller Targin, the Düsseldorf Regional Court has rejected Glenmark's claim for damages against Mundipharma. It deci ...

20 February 2024 by Konstanze Richter
Cases
SPC regulation

MSD vs. Viatris sees Paris Court of Appeal depart from previous SPC case law

It is rare for the Paris Court of Appeal to confirm a preliminary injunction in a patent dispute. But now, in doing so in an SPC dispute between MSD a ...

9 February 2024 by Konstanze Richter
People & Business
Germany

Gulde & Partner strengthens offices in Berlin and Düsseldorf

Berlin IP law firm Gulde is strengthening its two offices in Düsseldorf and the German capital. In Berlin, it is merging with local patent attorney fi ...

19 January 2024 by Mathieu Klos
Cases
Medical devices

UK invalidates two patents apiece for Abbott and Dexcom in vast CGM battle

In the next round of litigation between Abbott and Dexcom over continuous glucose monitoring devices, the UK High Court has found four patents invalid ...

18 January 2024 by Amy Sandys
Cases
Damages

CJEU confirms strict liability standard for losses due to PI

Patent owners who apply for preliminary injunctions against alleged infringers can be held liable for damages if the patent is later found to be inval ...

16 January 2024 by Konstanze Richter
Cases
Unified Patent Court

10x Genomics and NanoString yield no ground in first UPC Court of Appeal hearing

On Monday, the UPC Court of Appeal in Luxembourg heard its first case. 10x Genomics and NanoString fought hard in their appeal against a preliminary i ...

20 December 2023 by Mathieu Klos
Cases
mRNA vaccines

German Federal Patent Court changes its mind on CureVac mRNA patent

CureVac has today suffered a defeat in its dispute against BioNTech over mRNA patents, after the German Federal Patent Court nullified the German part ...

19 December 2023 by Konstanze Richter
Sponsored Content
Is the UPC trending towards bifurcation, but with a twist?

Is the UPC trending towards bifurcation, but with a twist?

Two of the big pharma/medtech cases at the UPC are arguably displaying a trend towards bifurcation, in particular due to the actions of the parties de ...

12 December 2023 by Simmons + Simmons LLP
Cases
mRNA technology

Dutch court nullifies one of Moderna's mRNA patents

Moderna has suffered another defeat in the international dispute over mRNA patents protecting COVID-19 vaccines. In the first judgment by a civil cour ...

7 December 2023 by Konstanze Richter
Cases
Medical devices

EPO Boards of Appeal revoke Edwards Lifesciences' heart-valve patent

Edwards Lifesciences and Meril have been fighting over heart-valve technology for years. Now the EPO has finally destroyed one of Edwards' patents. Th ...

5 December 2023 by Konstanze Richter
Cases
Cancer drug

Bayer and Weickmann successfully defend Nexavar patent in the second instance

Generic drug manufacturers selling copycat products for Bayer's cancer drug Nexavar in Germany could now face damages claims. In a recent ruling, the ...

1 December 2023 by Konstanze Richter
Popular